Coronavirus vaccine: Moderna to increase doses per vial

Published by Rizhlaine F. · Published on 13 February 2021 at 17h26 · Updated on 15 February 2021 at 15h22
As vaccination campaigns have been initiated worldwide, Moderna is in talks to increase by 50% vaccine doses per vial, so that they can move from 10 to 15 doses of vaccine per vial.

After laboratories raced to find a vaccine, now vaccination campaigns are sprinting. Well, the coronavirus epidemic does look like an obstacle course. Faced with the threat of variants, the biggest hope is now immunization coverage.

This Friday February 12, 2021, American company Moderna has said in a released passed to AFP they are willing to increase doses per vial by 50%. It would enable each vial to move from 10 to 15 doses of vaccine, so that shipping the preventive treatment to Covid-19 could be completed more easily. Furthermore, Moderna vaccine keeps on being rather effective against the South African variant. As for New York Times, they say that according to sources close to the file, the U.S. Food and Drug Administration (FDA) has already allowed a 40% increase of the size of vials.

Covid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en France Covid: Moderna vaccine soon to be manufactured in France
This Wednesday February 3, Deputy Minister for Industry Agnès Pannier-Runacher announced that in addition to deliveries scheduled already, Moderna Covid vaccine will be manufactured in France by a subcontractor. Production is to start “in March”.

Covid : le vaccin de Moderna efficace contre les variants britannique et sud-africainCovid : le vaccin de Moderna efficace contre les variants britannique et sud-africainCovid : le vaccin de Moderna efficace contre les variants britannique et sud-africainCovid : le vaccin de Moderna efficace contre les variants britannique et sud-africain Covid: Moderna to modify vaccine to improve its efficacy against variants
This Monday January 25, Moderna Therapeutics laboratory announced they were working on a new version of their vaccine, to make it more effective against variants, especially the South-African strain. That very same day, the group explained their product was effective against the two most spread variants in the world.

Practical information

Comments
Refine your search
Refine your search
Refine your search
Refine your search